Prognostic scores for cirrhotic patients admitted to an intensive care unit: Which consequences for liver transplantation?

Clinics and Research in Hepatology and Gastroenterology

Volumn 37, Issue 5, 2013, Pages 455-466

  Galbois, Arnaud ^a,b,c   Das, Vincent ^d   Carbonell, Nicolas ^e   Guidet, Bertrand ^a,b,f  

^a HÔpital Saint Antoine   (France)

^b SORBONNE UNIVERSITÉ   (France)

^c CENTRE DE RECHERCHE SAINT ANTOINE   (France)

^d Centre Hospitalier Intercommunal Andre Gregoire   (France)

^e HÔpital Saint Antoine   (France)

^f INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; HYPERTENSIVE AGENT;

ANTIVIRAL THERAPY; APACHE; ARTIFICIAL VENTILATION; ASCITES; CHILD TURCOTTE PUGH SCORE; CLIF SOFA SCORE; CRITICALLY ILL PATIENT; DECOMPENSATED LIVER CIRRHOSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE CLASSIFICATION; END STAGE LIVER DISEASE; GASTROINTESTINAL HEMORRHAGE; HIGH RISK PATIENT; HOSPITAL ADMISSION; HUMAN; INTENSIVE CARE UNIT; INTERNATIONAL NORMALIZED RATIO; LABORATORY TEST; LIVER CIRRHOSIS; LIVER DISEASE; LIVER FUNCTION; LIVER TRANSPLANTATION; LONG TERM SURVIVAL; MORTALITY; MULTIPLE ORGAN FAILURE; ORGAN DONOR; ORGAN SYSTEM FAILURE SCORE; OUTCOME ASSESSMENT; PREDICTIVE VALUE; PROGNOSIS; RATING SCALE; RECEIVER OPERATING CHARACTERISTIC; RENAL REPLACEMENT THERAPY; RISK FACTOR; SCORING SYSTEM; SEPSIS; SEPTIC SHOCK; SEQUENTIAL ORGAN FAILURE ASSESSMENT SCORE; SHORT SURVEY; SIMPLIFIED ACUTE PHYSIOLOGY SCORE; STANDARDIZED MORTALITY RATIO; SURGICAL MORTALITY; TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT; TREATMENT OUTCOME;

APACHE; CRITICAL ILLNESS; HOSPITAL MORTALITY; HUMANS; INTENSIVE CARE UNITS; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; ORGAN DYSFUNCTION SCORES; PATIENT OUTCOME ASSESSMENT; PROGNOSIS;

EID: 84886948679     PISSN: 22107401     EISSN: 2210741X     Source Type: Journal    
DOI: 10.1016/j.clinre.2013.05.001     Document Type: Short Survey

References (76)

1. Knaus W.A., Wagner D.P., Draper E.A., Zimmerman J.E., Bergner M., Bastos P.G., et al. The APACHE III prognostic system. Risk prediction of hospital mortality for critically ill hospitalized adults. Chest 1991, 100(6):1619-1636.
2. Pugh R.N., Murray-Lyon I.M., Dawson J.L., Pietroni M.C., Williams R. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 1973, 60(8):646-649.
3. Oellerich M., Burdelski M., Lautz H.U., Binder L., Pichlmayr R. Predictors of one-year pretransplant survival in patients with cirrhosis. Hepatology 1991, 14(6):1029-1034.
4. Murray K.F., Carithers R.L. AASLD practice guidelines: evaluation of the patient for liver transplantation. Hepatology 2005, 41(6):1407-1432.
5. Conn H.O. A peek at the Child-Turcotte classification. Hepatology 1981, 1(6):673-676.
6. Trey C., Burns D.G., Saunders S.J. Treatment of hepatic coma by exchange blood transfusion. N Engl J Med 1966, 274(9):473-481.
7. Lucey M.R., Brown K.A., Everson G.T., Fung J.J., Gish R., Keeffe E.B., et al. Minimal criteria for placement of adults on the liver transplant waiting list: a report of a national conference organized by the American Society of Transplant Physicians and the American Association for the Study of Liver Diseases. Liver Transpl Surg 1997, 3(6):628-637.
8. Malinchoc M., Kamath P.S., Gordon F.D., Peine C.J., Rank J.,Borg P.C. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology 2000, 31(4):864-871.
9. Kamath P.S., Wiesner R.H., Malinchoc M., Kremers W., Therneau T.M., Kosberg C.L., et al. A model to predict survival in patients with end-stage liver disease. Hepatology 2001, 33(2):464-470.
10. Wiesner R., Edwards E., Freeman R., Harper A., Kim R., Kamath P., et al. Model for end-stage liver disease (MELD) and allocation of donor livers. Gastroenterology 2003, 124(1):91-96.
11. Freeman R.B., Wiesner R.H., Edwards E., Harper A., Merion R., Wolfe R. Results of the first year of the new liver allocation plan. Liver Transpl 2004, 10(1):7-15.
12. Francoz C., Belghiti J., Castaing D., Chazouilleres O., Duclos-Vallee J.C., Duvoux C., et al. Model for end-stage liver disease exceptions in the context of the French model for end-stage liver disease score-based liver allocation system. Liver Transpl 2011, 17(10):1137-1151.
13. D'Amico G., Garcia-Tsao G., Pagliaro L. Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies. J Hepatol 2006, 44(1):217-231.
14. Sihler K.C., Napolitano L.M. Complications of massive transfusion. Chest 2010, 137(1):209-220.
15. Bosch J., Thabut D., Albillos A., Carbonell N., Spicak J., Massard J., et al. Recombinant factor VIIa for variceal bleeding in patients with advanced cirrhosis: a randomized, controlled trial. Hepatology 2008, 47(5):1604-1614.
16. Plessier A., Denninger M.H., Consigny Y., Pessione F., Francoz C., Durand F., et al. Coagulation disorders in patients with cirrhosis and severe sepsis. Liver Int 2003, 23(6):440-448.
17. Fourrier F. Severe sepsis, coagulation, and fibrinolysis: dead end or one way?. Crit Care Med 2012, 40(9):2704-2708.
18. Takemitsu T., Wada H., Hatada T., Ohmori Y., Ishikura K., Takeda T., et al. Prospective evaluation of three different diagnostic criteria for disseminated intravascular coagulation. Thromb Haemost 2011, 105(1):40-44.
19. Vincent J.L., Dubois M.J., Navickis R.J., Wilkes M.M. Hypoalbuminemia in acute illness: is there a rationale for intervention? A meta-analysis of cohort studies and controlled trials. Ann Surg 2003, 237(3):319-334.
20. Wang X., Li W., Lu J., Li N., Li J. Lipopolysaccharide suppresses albumin expression by activating NF-kappaB in rat hepatocytes. J Surg Res 2004, 122(2):274-279.
21. Chand N., Sanyal A.J. Sepsis-induced cholestasis. Hepatology 2007, 45(1):230-241.
22. Frenette A.J., Dufresne M.E., Bonhomme V., Albert M., Williamson D.R. Drug-induced hepatic cholestasis in the critically ill. Intensive Care Med 2011, 37(7):1225-1226.
23. Cheyron D., Bouchet B., Parienti J.J., Ramakers M., Charbonneau P. The attributable mortality of acute renal failure in critically ill patients with liver cirrhosis. Intensive Care Med 2005, 31(12):1693-1699.
24. Belcher J.M., Garcia-Tsao G., Sanyal A.J., Bhogal H., Lim J.K., Ansari N., et al. Association of AKI With mortality and complications in hospitalized patients with cirrhosis. Hepatology 2013, 57(2):753-762.
25. Figueroa-Ramos M.I., Arroyo-Novoa C.M., Lee K.A., Padilla G., Puntillo K.A. Sleep and delirium in ICU patients: a review of mechanisms and manifestations. Intensive Care Med 2009, 35(5):781-795.
26. Adam N., Kandelman S., Mantz J., Chretien F., Sharshar T. Sepsis-induced brain dysfunction. Expert Rev Anti Infect Ther 2013, 11(2):211-221.
27. Thabut D., Massard J., Gangloff A., Carbonell N., Francoz C., Nguyen-Khac E., et al. Model for end-stage liver disease score and systemic inflammatory response are major prognostic factors in patients with cirrhosis and acute functional renal failure. Hepatology 2007, 46(6):1872-1882.
28. Das V., Boelle P.Y., Galbois A., Guidet B., Maury E., Carbonell N., et al. Cirrhotic patients in the medical intensive care unit: early prognosis and long-term survival. Crit Care Med 2010, 38(11):2108-2116.
29. Le Gall J.R., Lemeshow S., Saulnier F. A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study. JAMA 1993, 270(24):2957-2963.
30. Minne L., Eslami S., de Keizer N., de Jonge E., de Rooij S.E., Abu-Hanna A. Effect of changes over time in the performance of a customized SAPS-II model on the quality of care assessment. Intensive Care Med 2012, 38(1):40-46.
31. Arabi Y., Ahmed Q.A., Haddad S., Aljumah A., Al-Shimemeri A. Outcome predictors of cirrhosis patients admitted to the intensive care unit. Eur J Gastroenterol Hepatol 2004, 16(3):333-339.
32. Knaus W.A., Draper E.A., Wagner D.P., Zimmerman J.E. APACHE II: a severity of disease classification system. Crit Care Med 1985, 13(10):818-829.
33. Castella X., Artigas A., Bion J., Kari A. A comparison of severity of illness scoring systems for intensive care unit patients: results of a multicenter, multinational study. The European/North American Severity Study Group. Crit Care Med 1995, 23(8):1327-1335.
34. Knaus W.A., Draper E.A., Wagner D.P., Zimmerman J.E. Prognosis in acute organ-system failure. Ann Surg 1985, 202(6):685-693.
35. Vincent J.L., Moreno R., Takala J., Willatts S., De Mendonca A., Bruining H., et al. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med 1996, 22(7):707-710.
36. Moreno R., Vincent J.L., Matos R., Mendonca A., Cantraine F., Thijs L., et al. The use of maximum SOFA score to quantify organ dysfunction/failure in intensive care. Results of a prospective, multicentre study. Working Group on Sepsis related Problems of the ESICM. Intensive Care Med 1999, 25(7):686-696.
37. Ferreira F.L., Bota D.P., Bross A., Melot C., Vincent J.L. Serial evaluation of the SOFA score to predict outcome in critically ill patients. JAMA 2001, 286(14):1754-1758.
38. Galbois A., Das V., Thabut D., Maury E., Ait-Oufella H., Housset C., et al. Beta-blockers have no effect on outcomes in patients with cirrhosis and severe infections. Hepatology 2011, 53(4):1412-1413.
39. Jazaeri F., Tavangar S.M., Ghazi-Khansari M., Khorramizadeh M.R., Mani A.R., Dehpour A.R. Cirrhosis is associated with development of tolerance to cardiac chronotropic effect of endotoxin in rats. Liver Int 2013, 33(3):368-374.
40. Pateron D., Tazi K.A., Sogni P., Heller J., Chagneau C., Poirel O., et al. Role of aortic nitric oxide synthase 3 (eNOS) in the systemic vasodilation of portal hypertension. Gastroenterology 2000, 119(1):196-200.
41. Wong F., Bernardi M., Balk R., Christman B., Moreau R., Garcia-Tsao G., et al. Sepsis in cirrhosis: report on the 7th meeting of the International Ascites Club. Gut 2005, 54(5):718-725.
42. Moreau R., Hadengue A., Soupison T., Kirstetter P., Mamzer M.F., Vanjak D., et al. Septic shock in patients with cirrhosis: hemodynamic and metabolic characteristics and intensive care unit outcome. Crit Care Med 1992, 20(6):746-750.
43. Bianchi G., Giovagnoli M., Sasdelli A.S., Marchesini G. Hepatic encephalopathy and health-related quality of life. Clin Liver Dis 2012, 16(1):159-170.
44. Francoz C., Glotz D., Moreau R., Durand F. The evaluation of renal function and disease in patients with cirrhosis. J Hepatol 2010, 52(4):605-613.
45. Bleibel W., Caldwell S.H., Curry M.P., Northup P.G. Peripheral platelet count correlates with liver atrophy and predicts long-term mortality on the liver transplant waiting list. Transpl Int 2013, 26(4):435-442. 10.1111/tri.12064.
46. Afdhal N., McHutchison J., Brown R., Jacobson I., Manns M., Poordad F., et al. Thrombocytopenia associated with chronic liver disease. J Hepatol 2008, 48(6):1000-1007.
47. Rodriguez-Roisin R., Krowka M.J. Hepatopulmonary syndrome - a liver-induced lung vascular disorder. N Engl J Med 2008, 358(22):2378-2387.
48. Levesque E., Hoti E., Jiabin J., Dellamonica J., Ichai P., Saliba F., et al. Respiratory impact of paracentesis in cirrhotic patients with acute lung injury. J Crit Care 2011, 26(3):257-261.
49. Wehler M., Kokoska J., Reulbach U., Hahn E.G., Strauss R. Short-term prognosis in critically ill patients with cirrhosis assessed by prognostic scoring systems. Hepatology 2001, 34(2):255-261.
50. Zauner C.A., Apsner R.C., Kranz A., Kramer L., Madl C., Schneider B., et al. Outcome prediction for patients with cirrhosis of the liver in a medical ICU: a comparison of the APACHE scores and liver-specific scoring systems. Intensive Care Med 1996, 22(6):559-563.
51. Aggarwal A., Ong J.P., Younossi Z.M., Nelson D.R., Hoffman-Hogg L., Arroliga A.C. Predictors of mortality and resource utilization in cirrhotic patients admitted to the medical ICU. Chest 2001, 119(5):1489-1497.
52. Rabe C., Schmitz V., Paashaus M., Musch A., Zickermann H., Dumoulin F.L., et al. Does intubation really equal death in cirrhotic patients? Factors influencing outcome in patients with liver cirrhosis requiring mechanical ventilation. Intensive Care Med 2004, 30(8):1564-1571.
53. Karvellas C.J., Pink F., McPhail M., Austin M., Auzinger G., Bernal W., et al. Bacteremia, acute physiology and chronic health evaluation II and modified end stage liver disease are independent predictors of mortality in critically ill nontransplanted patients with acute on chronic liver failure. Crit Care Med 2010, 38(1):121-126.
54. Levesque E., Hoti E., Azoulay D., Ichai P., Habouchi H., Castaing D., et al. Prospective evaluation of the prognostic scores for cirrhotic patients admitted to an intensive care unit. J Hepatol 2012, 56(1):95-102.
55. Tsai M.H., Chen Y.C., Ho Y.P., Fang J.T., Lien J.M., Chiu C.T., et al. Organ system failure scoring system can predict hospital mortality in critically ill cirrhotic patients. J Clin Gastroenterol 2003, 37(3):251-257.
56. Chen Y.C., Tsai M.H., Ho Y.P., Hsu C.W., Lin H.H., Fang J.T., et al. Comparison of the severity of illness scoring systems for critically ill cirrhotic patients with renal failure. Clin Nephrol 2004, 61(2):111-118.
57. Tsai M.H., Peng Y.S., Lien J.M., Weng H.H., Ho Y.P., Yang C., et al. Multiple organ system failure in critically ill cirrhotic patients. A comparison of two multiple organ dysfunction/failure scoring systems. Digestion 2004, 69(3):190-200.
58. Ho Y.P., Chen Y.C., Yang C., Lien J.M., Chu Y.Y., Fang J.T., et al. Outcome prediction for critically ill cirrhotic patients: a comparison of APACHE II and Child-Pugh scoring systems. J Intensive Care Med 2004, 19(2):105-110.
59. Cholongitas E., Senzolo M., Patch D., Kwong K., Nikolopoulou V., Leandro G., et al. Risk factors, sequential organ failure assessment and model for end-stage liver disease scores for predicting short-term mortality in cirrhotic patients admitted to intensive care unit. Aliment Pharmacol Ther 2006, 23(7):883-893.
60. Chen Y.C., Tian Y.C., Liu N.J., Ho Y.P., Yang C., Chu Y.Y., et al. Prospective cohort study comparing sequential organ failure assessment and acute physiology, age, chronic health evaluation III scoring systems for hospital mortality prediction in critically ill cirrhotic patients. Int J Clin Pract 2006, 60(2):160-166.
61. Cholongitas E., Betrosian A., Senzolo M., Shaw S., Patch D., Manousou P., et al. Prognostic models in cirrhotics admitted to intensive care units better predict outcome when assessed at 48h after admission. J Gastroenterol Hepatol 2008, 23(8 Pt 1):1223-1227.
62. Cavallazzi R., Awe O.O., Vasu T.S., Hirani A., Vaid U., Leiby B.E., et al. Model for End-Stage Liver Disease score for predicting outcome in critically ill medical patients with liver cirrhosis. J Crit Care 2012, 27(4):424. e1-6.
63. Juneja D., Gopal P.B., Kapoor D., Raya R., Sathyanarayanan M. Profile and outcome of patients with liver cirrhosis requiring mechanical ventilation. J Intensive Care Med 2012, 27(6):373-378.
64. Tu K.H., Jenq C.C., Tsai M.H., Hsu H.H., Chang M.Y., Tian Y.C., et al. Outcome scoring systems for short-term prognosis in critically ill cirrhotic patients. Shock 2011, 36(5):445-450.
65. Singh N., Gayowski T., Wagener M.M., Marino I.R. Outcome of patients with cirrhosis requiring intensive care unit support: prospective assessment of predictors of mortality. J Gastroenterol 1998, 33(1):73-79.
66. Kress J.P., Rubin A., Pohlman A.S., Hall J.B. Outcomes of critically ill patients denied consideration for liver transplantation. Am J Respir Crit Care Med 2000, 162(2 Pt 1):418-423.
67. Galbois A., Trompette M.L., Das V., Boelle P.Y., Carbonell N., Thabut D., et al. Improvement in the prognosis of cirrhotic patients admitted to an intensive care unit, a retrospective study. Eur J Gastroenterol Hepatol 2012, 24(8):897-904.
68. Lemeshow S., Le Gall J.R. Modeling the severity of illness of ICU patients. A systems update. JAMA 1994, 272(13):1049-1055.
69. Predicting outcome in ICU patients. 2nd European Consensus Conference in Intensive Care Medicine. Intensive Care Med 1994; 20(5):390-397.
70. Zauner C., Schneeweiss B., Schneider B., Madl C., Klos H., Kranz A., et al. Short-term prognosis in critically ill patients with liver cirrhosis: an evaluation of a new scoring system. Eur J Gastroenterol Hepatol 2000, 12(5):517-522.
71. Futagawa Y., Terasaki P.I., Waki K., Cai J., Gjertson D.W. No improvement in long-term liver transplant graft survival in the last decade: an analysis of the UNOS data. Am J Transplant 2006, 6(6):1398-1406.
72. Aggarwal A., Ong J.P., Goormastic M., Nelson D.R., Arroliga A.C., Farquhar L., et al. Survival and resource utilization in liver transplant recipients: the impact of admission to the intensive care unit. Transplant Proc 2003, 35(8):2998-3002.
73. Umgelter A., Lange K., Kornberg A., Buchler P., Friess H., Schmid R.M. Orthotopic liver transplantation in critically ill cirrhotic patients with multi-organ failure: a single-center experience. Transplant Proc 2011, 43(10):3762-3768.
74. Wong C.S., Lee W.C., Jenq C.C., Tian Y.C., Chang M.Y., Lin C.Y., et al. Scoring short-term mortality after liver transplantation. Liver Transpl 2010, 16(2):138-146.
75. Karvellas C.J., Lescot T., Goldberg P., Sharpe M.D., Ronco J.J., Renner E.L., et al. Liver transplantation in the critically ill: a multi-centre Canadian retrospective cohort study. Crit Care 2013, 17(1):R28.
76. Jalan R., Gines P., Olson J.C., Mookerjee R.P., Moreau R., Garcia-Tsao G., et al. Acute-on chronic liver failure. J Hepatol 2012, 57(6):1336-1348.